We are live on ! Find out more
FLNA

Filana Therapeutics

140 hedge funds and large institutions have $215M invested in Filana Therapeutics in 2023 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 55 increasing their positions, 31 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

77% more repeat investments, than reductions

Existing positions increased: 55 | Existing positions reduced: 31

11% more call options, than puts

Call options by funds: $65.2M | Put options by funds: $58.7M

2.81% more ownership

Funds ownership: 28.02%30.83% (+2.8%)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

8% less funds holding

Funds holding: 152140 (-12)

25% less capital invested

Capital invested by funds: $287M → $215M (-$71.4M)

36% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 25

Holders
140
Holders Change
-12
Holders Change %
-7.89%
% of All Funds
2.22%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
16
Increased
55
Reduced
31
Closed
25
Calls
$65.2M
Puts
$58.7M
Net Calls
+$6.47M
Net Calls Change
+$3.48M

FLNA Hedge Fund Activity: Q3 2023 in Review

140 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Filana Therapeutics (FLNA) for Q3 2023, worth a combined $215M — down 25% from $287M a quarter earlier.

Sellers outnumbered buyers: 25 funds closed out of FLNA and 16 opened new positions — a net loss of 9 holders — while 31 trimmed existing stakes and 55 added.

The largest buyer was Bank of America, adding an estimated $8.88M. The largest seller was Susquehanna International Group, cutting an estimated $3.15M.

  • 140 institutional investors held Filana Therapeutics (FLNA) as of Q3 2023, down from 152 in Q2 2023.
  • Funds reported $215M of Filana Therapeutics stock for Q3 2023, down 25% quarter-over-quarter.
  • 16 funds opened new Filana Therapeutics positions in Q3 2023 and 25 closed out, a net change of -9 holders.
  • The largest Filana Therapeutics buyer in Q3 2023 was Bank of America, an estimated $8.88M added.
  • The largest Filana Therapeutics seller in Q3 2023 was Susquehanna International Group, an estimated $3.15M sold.

Based on aggregated 13F filings for Q3 2023.